Commentary

Commentary

Cancer Breakthroughs Threatened by D.C.’s Price Controls

Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, reductions in smoking and improvements in disease management and earlier diagnosis have resulted in a 34% drop in ...
Commentary

House GOP must promote commonsense health care reform

Nearly half of Americans struggle to pay for health care, according to recent polling from independent health policy research organization KFF. If congressional Republicans hope to maintain their majority in the midterm elections this fall, then they need to address those concerns with credible, patient-centered reforms. They have already begun ...
Commentary

In the rush to hold insurers to account, don’t forget about hospitals

When asked to account for the skyrocketing cost of health coverage before two House committees last Thursday, the chief executives of five of America’s largest health insurance companies pointed fingers. Don’t look at us, they said. Look at hospitals and drugmakers. Read the op-ed here.
California

California needs budget restraint not double-digit spending increases

Gov. Gavin Newsom is proposing a nearly 9% increase in total state spending for the upcoming fiscal year – that’s a $350 billion budget, more than $8,800 per Californian. Yet, for unions and progressive politicians, this enormous sum is too austere. They are calling on the state to backfill federal ...
Commentary

Sorry, but single-payer won’t fix American health care

Affordability is becoming the watchword for Republicans and Democrats alike this election year. Progressives in Senate races from Maine to Illinois to Minnesota are putting Medicare for All at the center of their agenda for making health care affordable. Polling shows that some two-thirds of Americans support the policy. The ...
Commentary

Open, Competitive Market Will Make Trump’s Health Plan Great

President Trump’s recently released Great Healthcare Plan offers several welcome reforms. It endeavors to put patients first by fostering greater price transparency and taking steps to lower health insurance premiums. Its approach to prescription drug policy is a bit more mixed. Read the op-ed here.
Commentary

CMS Officials Are Undermining Trump’s Push For Affordable Drugs

Officials at the Centers for Medicare and Medicaid Services just undermined President Trump’s efforts to make prescription drugs more affordable. Earlier this week, CMS announced the next 15 medicines that will face price caps under Medicare’s Drug Price “Negotiation” Program, a core component of the Inflation Reduction Act signed into ...
Commentary

The ‘Medicare-For-All’ Delusion

As Congress looks for ways to bring down the cost of insurance, a growing number of Democrats are pushing to get rid of insurance altogether and make the federal government the sole funder of health care in this country. Several progressive Senate candidates have put Medicare for All at the ...
Commentary

Proposed patent tax offers a dangerous ‘solution’ to a non-existent problem

US Commerce Secretary Howard Lutnick believes taxpayers are getting short-changed by America’s patent system. Last year, he argued that the federal government should be entitled to 50% of the revenue universities earn from licensing the patented discoveries they’ve made with help from federally funded research grants. Lutnick is deeply mistaken. ...
Business & Economics

Competition Begets Better Banking Data Than Regulation

As it works to determine how to safeguard the sharing of and access to consumer financial data, the Consumer Financial Protection Bureau (CFPB) faces a clear choice. It can allow market-based frameworks developed by the private sector to continue evolving, stepping in only where genuine gaps or abuses emerge. Or ...
Commentary

Cancer Breakthroughs Threatened by D.C.’s Price Controls

Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, reductions in smoking and improvements in disease management and earlier diagnosis have resulted in a 34% drop in ...
Commentary

House GOP must promote commonsense health care reform

Nearly half of Americans struggle to pay for health care, according to recent polling from independent health policy research organization KFF. If congressional Republicans hope to maintain their majority in the midterm elections this fall, then they need to address those concerns with credible, patient-centered reforms. They have already begun ...
Commentary

In the rush to hold insurers to account, don’t forget about hospitals

When asked to account for the skyrocketing cost of health coverage before two House committees last Thursday, the chief executives of five of America’s largest health insurance companies pointed fingers. Don’t look at us, they said. Look at hospitals and drugmakers. Read the op-ed here.
California

California needs budget restraint not double-digit spending increases

Gov. Gavin Newsom is proposing a nearly 9% increase in total state spending for the upcoming fiscal year – that’s a $350 billion budget, more than $8,800 per Californian. Yet, for unions and progressive politicians, this enormous sum is too austere. They are calling on the state to backfill federal ...
Commentary

Sorry, but single-payer won’t fix American health care

Affordability is becoming the watchword for Republicans and Democrats alike this election year. Progressives in Senate races from Maine to Illinois to Minnesota are putting Medicare for All at the center of their agenda for making health care affordable. Polling shows that some two-thirds of Americans support the policy. The ...
Commentary

Open, Competitive Market Will Make Trump’s Health Plan Great

President Trump’s recently released Great Healthcare Plan offers several welcome reforms. It endeavors to put patients first by fostering greater price transparency and taking steps to lower health insurance premiums. Its approach to prescription drug policy is a bit more mixed. Read the op-ed here.
Commentary

CMS Officials Are Undermining Trump’s Push For Affordable Drugs

Officials at the Centers for Medicare and Medicaid Services just undermined President Trump’s efforts to make prescription drugs more affordable. Earlier this week, CMS announced the next 15 medicines that will face price caps under Medicare’s Drug Price “Negotiation” Program, a core component of the Inflation Reduction Act signed into ...
Commentary

The ‘Medicare-For-All’ Delusion

As Congress looks for ways to bring down the cost of insurance, a growing number of Democrats are pushing to get rid of insurance altogether and make the federal government the sole funder of health care in this country. Several progressive Senate candidates have put Medicare for All at the ...
Commentary

Proposed patent tax offers a dangerous ‘solution’ to a non-existent problem

US Commerce Secretary Howard Lutnick believes taxpayers are getting short-changed by America’s patent system. Last year, he argued that the federal government should be entitled to 50% of the revenue universities earn from licensing the patented discoveries they’ve made with help from federally funded research grants. Lutnick is deeply mistaken. ...
Business & Economics

Competition Begets Better Banking Data Than Regulation

As it works to determine how to safeguard the sharing of and access to consumer financial data, the Consumer Financial Protection Bureau (CFPB) faces a clear choice. It can allow market-based frameworks developed by the private sector to continue evolving, stepping in only where genuine gaps or abuses emerge. Or ...
Scroll to Top